[{"Assets_0_FY_USD":322864000.0,"EarningsPerShareBasic_1_FY_USD":-0.09,"EarningsPerShareBasic_4_FY_USD":0.34,"EarningsPerShareDiluted_1_FY_USD":-0.09,"EarningsPerShareDiluted_4_FY_USD":0.34,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":27472000.0,"NetIncomeLossConverted_4_FY_USD":3913000.0,"RevenuesConverted_1_FY_USD":38205000.0,"RevenuesConverted_4_FY_USD":128622000.0,"StockholdersEquity_0_FY_USD":169648000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":11573000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":11445000.0,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170302"}]